Multiple biomarkers and the risk of incident hypertension.

PubWeight™: 1.34‹?› | Rank: Top 10%

🔗 View Article (PMID 17242302)

Published in Hypertension on January 22, 2007

Authors

Thomas J Wang1, Philimon Gona, Martin G Larson, Daniel Levy, Emelia J Benjamin, Geoffrey H Tofler, Paul F Jacques, James B Meigs, Nader Rifai, Jacob Selhub, Sander J Robins, Christopher Newton-Cheh, Ramachandran S Vasan

Author Affiliations

1: Framingham Heart Study, Framingham, Mass, USA. tjwang@partners.org

Articles citing this

Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanisms. Psychol Bull (2011) 4.27

Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study. Circulation (2008) 1.26

Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease. Acta Physiol (Oxf) (2009) 1.18

Relations of biomarkers representing distinct biological pathways to left ventricular geometry. Circulation (2008) 1.09

Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: the Women's Genome Health Study. J Hypertens (2009) 1.03

New role for plasmin in sodium homeostasis. Curr Opin Nephrol Hypertens (2010) 0.99

Risk models to predict hypertension: a systematic review. PLoS One (2013) 0.96

C-reactive protein and hypertension. J Hum Hypertens (2013) 0.94

Prediction of incident hypertension risk in women with currently normal blood pressure. Am J Med (2009) 0.93

Lipoprotein subclass abnormalities and incident hypertension in initially healthy women. Clin Chem (2011) 0.92

Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study. Atherosclerosis (2013) 0.92

Urinary albumin as a marker of future blood pressure and hypertension in the general population. Medicine (Baltimore) (2015) 0.91

Genetics of the ceramide/sphingosine-1-phosphate rheostat in blood pressure regulation and hypertension. BMC Genet (2011) 0.88

Novel risk factors in long-term hypertension incidence in type 1 diabetes mellitus. Am Heart J (2010) 0.87

Periodontal disease and incidence of hypertension in the health professionals follow-up study. Am J Hypertens (2012) 0.85

A comparison of methods for assessing mortality risk. Am J Hum Biol (2014) 0.85

Multiple biomarker prediction of type 2 diabetes. Diabetes Care (2009) 0.85

Endothelial progenitor cells in adolescents: impact of overweight, age, smoking, sport and cytokines in younger age. Clin Res Cardiol (2008) 0.83

Reducing the number of parameters in 1D arterial blood flow modeling: less is more for patient-specific simulations. Am J Physiol Heart Circ Physiol (2015) 0.82

The anti-fibrinolytic SERPIN, plasminogen activator inhibitor 1 (PAI-1), is targeted to and released from catecholamine storage vesicles. Blood (2011) 0.82

Circulating inflammatory and endothelial markers and risk of hypertension in white and black postmenopausal women. Clin Chem (2011) 0.82

24-Hour ambulatory blood pressure associates inversely with prostaglandin F(2α), interleukin-6 and F(2)-isoprostane formation in a Swedish population of older men. Int J Clin Exp Med (2012) 0.81

Racial Differences in Natriuretic Peptide Levels: The Dallas Heart Study. JACC Heart Fail (2015) 0.81

Role of fibrinogen in cerebrovascular dysfunction after traumatic brain injury. Brain Inj (2013) 0.80

Red blood cell fatty acids and biomarkers of inflammation: a cross-sectional study in a community-based cohort. Atherosclerosis (2015) 0.79

Association of high blood pressure with renal insufficiency: role of albuminuria, from NHANES, 1999-2006. PLoS One (2012) 0.78

Homocysteine as a risk factor for hypertension: a 2-year follow-up study. PLoS One (2014) 0.78

CXCL5 polymorphisms are associated with variable blood pressure in cardiovascular disease-free adults. Hum Genomics (2012) 0.77

Network-based analysis of the sphingolipid metabolism in hypertension. Front Genet (2015) 0.77

Fcγ receptors and ligands and cardiovascular disease. Circ Res (2015) 0.77

Hypertension is associated with preamyloid oligomers in human atrium: a missing link in atrial pathophysiology? J Am Heart Assoc (2014) 0.76

Cardiac target organ damage in hypertension: insights from epidemiology. Curr Hypertens Rep (2014) 0.76

Association of parental hypertension with concentrations of select biomarkers in nonhypertensive offspring. Hypertension (2008) 0.76

Plasma Inflammatory Markers and the Risk of Developing Hypertension in Men. J Am Heart Assoc (2015) 0.76

Oral paricalcitol versus oral calcitriol in continuous ambulatory peritoneal dialysis patients with secondary hyperparathyroidism. Clin Exp Nephrol (2013) 0.76

Higher serum concentrations of N-terminal pro-B-type natriuretic peptide associate with prevalent hypertension whereas lower associate with incident hypertension. PLoS One (2015) 0.75

Relationship between plasma plasminogen activator inhibitor-1 and hypertension in American Indians: findings from the Strong Heart Study. J Hypertens (2017) 0.75

Should Pre-hypertension Be Treated? Curr Hypertens Rep (2017) 0.75

Articles by these authors

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med (2008) 57.29

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science (2007) 51.70

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98

Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation (2008) 26.42

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation (2003) 23.97

Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74

Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet (2008) 20.73

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 16.52

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol (2002) 16.25

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23

Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med (2006) 15.60

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA (2007) 15.32

Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation (2007) 12.79

Obesity and the risk of heart failure. N Engl J Med (2002) 12.58

Metabolite profiles and the risk of developing diabetes. Nat Med (2011) 12.22

Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10

Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med (2002) 11.20

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09

Variants in MTNR1B influence fasting glucose levels. Nat Genet (2008) 10.85

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43

Long-term trends in the incidence of and survival with heart failure. N Engl J Med (2002) 10.37

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14

The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol (2007) 9.90

Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med (2008) 9.83

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA (2007) 9.68

C-reactive protein levels and outcomes after statin therapy. N Engl J Med (2005) 9.47

Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation (2010) 9.09

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90

Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation (2004) 8.80

Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med (2007) 8.59

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation (2005) 8.54

Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation (2002) 8.49

Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension (2004) 8.27

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54

Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47

Plasma adiponectin levels and risk of myocardial infarction in men. JAMA (2004) 7.46

Predictors of new-onset kidney disease in a community-based population. JAMA (2004) 7.45